Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients

Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients

ObjectiveTo explore the efficacy and safety of intermittent, oral famciclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients.MethodWe retrospectively analyzed the incidence of bortezomib treatment-related varicella-zoster virus reactivation in 719 newly-diagnosed multi...

Full description

Bibliographic Details
Main Authors: Gaofeng Zheng, Fangshu Guan, Xiaoyan Han, Li Yang, Yi Zhao, Yang Yang, Enfang Zhang, Jingsong He, Donghua He, Wenjun Wu, He Huang, Zhen Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
intermittent famciclovir
prophylaxis
herpes zoster
multiple myeloma
bortezomib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.843032/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.843032/full

Similar Items